Immunoassay Instruments Market

Global Immunoassay Instruments Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS10160
Available Format:
Category : Biotechnology

The immunoassay instruments market is growing with a considerable rate due to rising incidence of chronic infectious diseases, increasing preference for personalized medicine, and technological advancements. Investments in emerging economies, and focus on developing compact, reliable and portable immunoassay instruments are some of the factors giving ample opportunities to the immunoassay instruments market to grow in the coming years.

Immunoassay is a laboratory based diagnostic procedure that is performed using an immunological reaction of antibodies. The formation of antibody antigen complexes in blood samples and other body fluids are measured by immunoassay instruments and are usually engaged to detect analytes in quantitative or qualitative manner. Qualitative analyses of immunoassay test include immunoassay tests by detecting human chorionic gonadotropin in urine samples for pregnancy. Immunoassay is done in multiple steps with reagents being added and washed away at different points during the assay.

Calibrators, solutions that contain analyte and the concentration of analyte is known to them, is generally employed in the immunoassay. Currently, the immunoassay tests are discovering new avenues of applications in identifying infectious diseases, detection of cancer biomarkers, toxicology testing and other drug monitoring tests. Immunoassay techniques are particularly suited for examining compounds present in extremely low concentration, such as in nano gram and Pico gram, and without any previous treatments to improve its detection. 

To allow detection of antibodies and antigens, immunoassays utilize a range of different labels such as radioactive isotopes, enzymes, fluorogenic reporters, DNA reporters, labeless immunoassay, and electrochemiluminescent tags. Enzymes are mostly used in immunoassay as a label as they produce a visible color change in the presence of certain reagents. Immunoassays are mostly used in sports anti doping laboratories to test athlete’s blood samples for forbidden recombinant human growth hormone. Clinical tests also use immunoassays in many applications such as home pregnancy tests, which detect the pregnancy marker human chorionic gonadotropin.

On the basis of technology, the immunoassay instruments market can be categorized as enzyme-linked immunosorbent assay (ELISA), radioimmunoassay, rapid tests, polymerase chain reaction, western blot, and ELISPOT. Enzyme-linked immunosorbent assay includes 1st generation ELISA tests, 2nd generation ELISA tests, 3rd generation ELISA tests and 4th generation ELISA tests.

The immunoassay instruments market can be categorized on the basis of applications as oncology, endocrinology, autoimmune disorders, bone and mineral disorders, allergy, infectious diseases, neonatal screening, hematology, blood screening, cardiology, stool testing, and toxicology. On the basis of end users, the immunoassay instruments market can be categorized as laboratories, pharmaceutical companies, academic research centers, hospitals, patient self testing, biotechnology companies, ambulatory centers, blood banks, and physician’s offices.

Some of the factors driving the immunoassay instruments market are enhanced discovery of specific biomarkers, extensive use of immunoassays in oncology and rising geriatric population. Implementation of excise duty by the U.S. government and high cost associated with technologically advanced immunoassay systems are some of the factors restraining the immunoassay instruments market to some extent.

North America dominates the immunoassay instruments market due to expanding biotechnology and pharmaceutical industries, rising incidences of chronic diseases, government support and the launch of new products in the region. Asia-Pacific is expected to grow at the highest rate in the coming years.

Some of the competitors in the immunoassay instruments market are Beckman Coulter, Inc., F. Hoffman-La Roche, Ltd., Thermo Fisher Scientific, Ortho Clinical Diagnostics, BioMerieux, Inc., Abbott Laboratories, Sysmex Corporation, DiaSorin S.p.A., Siemens Healthcare, and Merck Millipore Corporation.


Report Coverage

  • Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
  • Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
  • Uncovers potential demands in the market
  • Porter analysis identifies competitive forces within the market
  • Provides information on the historical and current market size and the future potential of the market
  • Provides sizes of key regional markets using yardsticks of segments, applications, and segments of applications
  • Highlights the competitive scenario of the market, major competitors, and benchmarking
  • Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics. Profiles provide better understanding of competition as well as the demands of the market.

Place An Order

Single User License

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry